New York
Generalized anxiety disorder clinical trials in New York
12 generalized anxiety disorder studies are recruiting participants at sites in 8 cities across New York as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every New York city with a recruiting study
Recently updated studies in New York
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Recruiting in
- Brooklyn · New York
- Registry record
- NCT07759128 · updated
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Recruiting in
- Jamaica · New York · The Bronx
- Registry record
- NCT07767903 · updated
A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Recruiting in
- Jamaica · New York
- Registry record
- NCT07786454 · updated
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
- Phase 2
- All ages
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Recruiting in
- Brooklyn
- Registry record
- NCT06480383 · updated
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Recruiting in
- Brooklyn · Buffalo · Staten Island
- Registry record
- NCT06701903 · updated
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Recruiting in
- Brooklyn
- Registry record
- NCT07807865 · updated
A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD Treatment
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Recruiting in
- New York
- Registry record
- NCT07856420 · updated
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
- Phase 2
- Ages 18 to 74
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Recruiting in
- New York
- Registry record
- NCT07489651 · updated
Singula Phase 0.1 Primary Care Pilot
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Singula Health, Inc.
- Recruiting in
- Mount Kisco
- Registry record
- NCT07834684 · updated
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Brooklyn
- Registry record
- NCT06846320 · updated
Triage Survey for Psychiatry Research Eligibility
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Adams Clinical
- Recruiting in
- New York · The Bronx
- Registry record
- NCT05800925 · updated
Mind-Body Skills Group for Graduate Students
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Weill Medical College of Cornell University
- Recruiting in
- White Plains
- Registry record
- NCT05447689 · updated
Source: ClinicalTrials.gov. Data processed . See every generalized anxiety disorder study recruiting in New York on ClinicalTrials.gov.
Ask about studies in New York
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
GAD Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections